Here are our introductory comments:
Dr. Ana Mingorance is a neuroscientist specialist in genetic epilepsy and an independent consultant in orphan drug development for neurological diseases. She is a scientific advisor for the Davet syndrome European Federation. Ana is a strong advocate for patient involvement in drug discovery and developments and frequently joins forces with the patient communities to accelerate the development of new treatments.
Dr. Mingorance received her PhD from the University of Barcelona in Spain and completed her postdoctoral fellowship at the University of British Columbia in Canada.